Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion type Assertion NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_head.
- NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion description "[Brain imaging studies using positron emission tomography and single photon emission computed tomography have shown that reduction in brain 5-hydroxytryptamine type 2 (5-HT(2)) receptors may be associated with prevention of or relief from depressive symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion evidence source_evidence_literature NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion SIO_000772 15948763 NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion wasDerivedFrom befree-20150227 NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.
- NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_assertion wasGeneratedBy ECO_0000203 NP471493.RA3cjdT2WJdoW87vjqkpiGbFQxC1F4w23DjFHW1TR70N8130_provenance.